Application of the key characteristics of carcinogens in cancer hazard identification

Abstract Smith et al. (Env. Health Perspect. 124: 713, 2016) identified 10 key characteristics (KCs), one or more of which are commonly exhibited by established human carcinogens. The KCs reflect the properties of a cancer-causing agent, such as ‘is genotoxic,’ ‘is immunosuppressive’ or ‘modulates receptor-mediated effects,’ and are distinct from the hallmarks of cancer, which are the properties of tumors. To assess feasibility and limitations of applying the KCs to diverse agents, methods and results of mechanistic data evaluations were compiled from eight recent IARC Monograph meetings. A systematic search, screening and evaluation procedure identified a broad literature encompassing multiple KCs for most (12/16) IARC Group 1 or 2A carcinogens identified in these meetings. Five carcinogens are genotoxic and induce oxidative stress, of which pentachlorophenol, hydrazine and malathion also showed additional KCs. Four others, including welding fumes, are immunosuppressive. The overall evaluation was upgraded to Group 2A based on mechanistic data for only two agents, tetrabromobisphenol A and tetrachloroazobenzene. Both carcinogens modulate receptor-mediated effects in combination with other KCs. Fewer studies were identified for Group 2B or 3 agents, with the vast majority (17/18) showing only one or no KCs. Thus, an objective approach to identify and evaluate mechanistic studies pertinent to cancer revealed strong evidence for multiple KCs for most Group 1 or 2A carcinogens but also identified opportunities for improvement. Further development and mapping of toxicological and biomarker endpoints and pathways relevant to the KCs can advance the systematic search and evaluation of mechanistic data in carcinogen hazard identification.

[1]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[2]  E. Dybing,et al.  Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. , 1999, IARC scientific publications.

[3]  Jane Liaw,et al.  2,4-dichlorophenoxyacetic acid (2,4-D) and risk of non-Hodgkin lymphoma: a meta-analysis accounting for exposure levels. , 2017, Annals of epidemiology.

[4]  Robert J Kavlock,et al.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.

[5]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[6]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[7]  Ellen Mantus,et al.  Using 21st Century Science to Improve Risk-Related Evaluations , 2017 .

[8]  Anna C. Salzberg,et al.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead , 2015, Carcinogenesis.

[9]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[10]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[11]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[12]  Kurt Straif,et al.  Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid. , 2015, The Lancet. Oncology.

[13]  Kurt Straif,et al.  Future priorities for IARC monographs. , 2008, The Lancet Oncology.

[14]  Andrew Worth,et al.  Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making , 2015, Environmental health perspectives.

[15]  Kurt Straif,et al.  Carcinogenicity of consumption of red and processed meat. , 2015, The Lancet. Oncology.

[16]  K. Straif,et al.  Carcinogenicity of some industrial chemicals. , 2016, The Lancet Oncology.

[17]  K. Guyton,et al.  Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides , 2016, Environmental health perspectives.

[18]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[19]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[20]  Sean Harrison,et al.  Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis , 2017, Cancer Causes & Control.

[21]  K. Straif,et al.  Carcinogenicity of pentachlorophenol and some related compounds. , 2016, The Lancet. Oncology.

[22]  K. Straif,et al.  Use of mechanistic data in IARC evaluations , 2008, Environmental and molecular mutagenesis.

[23]  Paolo Vineis,et al.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. , 2013, Carcinogenesis.

[24]  Ivan Rusyn,et al.  Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate. , 2012, Mutation research.

[25]  I. O'neill,et al.  Preamble to the IARC Monographs , 2009 .

[26]  Sarah J Lewis,et al.  The albatross plot: A novel graphical tool for presenting results of diversely reported studies in a systematic review , 2017, Research synthesis methods.

[27]  Linda S Birnbaum,et al.  Informing 21st-Century Risk Assessments with 21st-Century Science , 2016, Environmental health perspectives.

[28]  M. Fielden,et al.  Modernizing Human Cancer Risk Assessment of Therapeutics. , 2017, Trends in pharmacological sciences.

[29]  Kurt Straif,et al.  Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. , 2015, The Lancet. Oncology.

[30]  Weihsueh A. Chiu,et al.  Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental Chemicals , 2012, Environmental health perspectives.

[31]  Ivan Rusyn,et al.  Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups. , 2018, ALTEX.

[32]  S. Yufit.  Role of electronic factors in the formation of a standard, quasi-stable mixture of toxic polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans , 1999 .

[33]  Michael E. McManus,et al.  Some industrial chemicals , 2000 .

[34]  M E Meek,et al.  New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis , 2013, Journal of applied toxicology : JAT.

[35]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[36]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[37]  Per Gustavsson,et al.  IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans , 2015, Environmental health perspectives.

[38]  K. Straif,et al.  Some chemicals that cause tumours of the urinary tract in rodents. , 2017, The Lancet. Oncology.

[39]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[40]  Karen Muller,et al.  Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide. , 2017, The Lancet. Oncology.

[41]  P. Bertazzi,et al.  IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.

[42]  Jiri Aubrecht,et al.  Community address: www.elsevier.com/locate/mutres Review , 2022 .

[43]  Steven K. Gibb.  Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[44]  K. Straif,et al.  Carcinogenicity of drinking coffee, mate, and very hot beverages. , 2016, The Lancet. Oncology.